Full history for every metric is available with a Kvantra account
Stock profile
Cepheid (CPHD)
Current price
52.95 USD0.00%
Last close 4 Nov 2016Benchmarks
Key financial summary
Financials in USD| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 212 | 278 | 331 | 401 | 470 | 539 | 596 |
| Operating profit | $m | -31 | -21 | |||||
| Net profit | $m | -6 | 3 | -20 | -18 | -50 | -49 | -38 |
| EPS reported | $ | -0.67 | -0.52 | |||||
| Operating cashflow per share | $ | - | 0.43 | |||||
| Capex per share | $ | - | 0.52 | |||||
| FCF per share | $ | - | -0.09 | |||||
| Free cash flow | $m | -7 | -21 | |||||
| Net debt | $m | -7 | -48 | |||||
| Book value equity | $m | 370 | 381 | |||||
| Book value per share | $ | 5.14 | 5.22 | |||||
| Number of shares | m | 71.93 | 72.89 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 7.10 | 10.29 | |||||
| P/S LTM | x | 4.88 | 0.00 | |||||
| P/FCF LTM | x | -398.05 | 0.00 | |||||
| EV/EBITDA LTM | x | 253.43 | 18.15 | |||||
| EV/Sales LTM | x | - | 0.38 | |||||
| Earnings Yield LTM | % | - | -1.27% | |||||
| FCF Yield | % | -0.25% | - | |||||
| Quality | ||||||||
| ROE | % | - | -13.40% | |||||
| ROIC | % | - | -4.37% | |||||
| Operating margin | % | - | -5.73% | |||||
| Gross margin | % | - | 49.89% | |||||
| FCF/Sales | % | - | -1.23% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +14.56% | +13.99% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | - | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | - | 0.00% | |||||
| FCF/Debt | x | -0.02 | -0.06 | |||||
| Net Debt/EBITDA | x | - | 18.15 | |||||
| EBIT/Net interest | x | - | -2.11 | |||||
| Net debt/market cap | % | -0.28% | - | |||||
| Net debt/Equity | x | -0.02 | -0.13 | |||||
| Gross debt/equity | x | 0.85 | 0.84 | |||||
Company overview
No description available.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
CP
Cepheid (CPHD)
CPHD · NASDAQ · Healthcare
52.95 USD0.00%
Benchmarks
Financialsin USD
20142015TTM
Total revenue $m470539596
Operating profit $m-31-21
Net profit $m-50-49-38
EPS reported $-0.67-0.52
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free